ANGELA VEDIZ: Open Payments
NPI 1629066659 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 87 payments from 13 companies in 2025. Trend: 2023 $1,644 · 2024 $1,329 · 2025 $1,905
Food & beverage: $1,778Education: $127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $492 |
| Janssen Biotech, Inc. | 16 | $380 |
| Novartis Pharmaceuticals Corporation | 14 | $200 |
| GENZYME CORPORATION | 6 | $181 |
| LEO Pharma Inc. | 9 | $160 |
| Organogenesis Inc. | 3 | $114 |
| UCB, Inc. | 5 | $98 |
| Lilly USA, LLC | 6 | $97 |
| Amgen Inc. | 3 | $56 |
| PFIZER INC. | 3 | $46 |
Products named: TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, ADBRY, COSENTYX, Bimzelx, TALTZ.
Industry payments across MO — which companies pay providers there.
